Stephen Hoge serves as Executive at Moderna, Inc., where they oversee executive responsibilities. Since joining the company, Stephen Hoge has executed 703 insider transactions totaling $295.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 23, 2020 involved selling 385 shares valued at $8.7K.
Stephen Hoge currently holds 1,454,905 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Hoge has been a net seller of MRNA stock. They have purchased $0 and sold $295.8M worth of shares.
Stephen Hoge's most recent insider trade was on Jan 23, 2020, when they sold 385 shares at $22.53 per share.
Get notified when new Form 4 filings are submitted
| $19.14 |
| Discretionary |
| Dec 11, 2018 | MRNA | $0 | Conversion | 458 | $N/A | Discretionary |